BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36065133)

  • 21. MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR.
    Jia T; Ren Y; Wang F; Zhao R; Qiao B; Xing L; Ou L; Guo B
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathobiological role of cleft palate transmembrane protein 1 family proteins in oral squamous cell carcinoma.
    Inoue K; Hatano K; Hanamatsu Y; Saigo C; Kito Y; Bunai K; Shibata T; Takeuchi T
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):851-859. PubMed ID: 30635792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of c-Fos on the prognosis, proliferation, and invasion of oral squamous cell carcinoma.
    Peng L; Sun E; Zhang J; Cai L; Zheng J; Zeng Y
    Oral Dis; 2024 Feb; ():. PubMed ID: 38326698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of PDIA3 in oral squamous cell carcinoma and its value as A diagnostic and prognostic biomarker.
    Wang L; Wang X; Zhang J; Duan J; Tang C; Zhang L; Zeng H; Li H; Li Y; Zhou Y
    Heliyon; 2023 Dec; 9(12):e22596. PubMed ID: 38213579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting the Presence of Oral Squamous Cell Carcinoma Using Commonly Dysregulated MicroRNA in Oral Swirls.
    Yap T; Koo K; Cheng L; Vella LJ; Hill AF; Reynolds E; Nastri A; Cirillo N; Seers C; McCullough M
    Cancer Prev Res (Phila); 2018 Aug; 11(8):491-502. PubMed ID: 29764807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic and clinicopathological significance of cytocapsular tubes in oral squamous cell carcinoma.
    Wang W; Xie N; Yi C; Zhang M; Xiong G; Xu X; Hou J; Wang C
    J Oral Pathol Med; 2022 Jul; 51(6):520-528. PubMed ID: 35652154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulated microRNA-149-3p triggers malignant development and predicts worse prognosis in oral squamous cell carcinoma.
    Shen Q; Xiong P; Yang D; Chen L
    Arch Oral Biol; 2022 Feb; 134():105336. PubMed ID: 34891100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non‑coding RNA AFAP1‑AS1 facilitates the growth and invasiveness of oral squamous cell carcinoma by regulating the miR‑145/HOXA1 axis.
    Li M; Yu D; Li Z; Zhao C; Su C; Ning J
    Oncol Rep; 2021 Mar; 45(3):1094-1104. PubMed ID: 33650645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.
    Kurihara-Shimomura M; Sasahira T; Nakamura H; Nakashima C; Kuniyasu H; Kirita T
    J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct genetic association at the PLCE1 locus with oesophageal squamous cell carcinoma in the South African population.
    Bye H; Prescott NJ; Lewis CM; Matejcic M; Moodley L; Robertson B; Rensburg Cv; Parker MI; Mathew CG
    Carcinogenesis; 2012 Nov; 33(11):2155-61. PubMed ID: 22865593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of Kif5b protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma.
    Luan YJ; Xu Y; Cai J; Dou Y; Yu WJ; Wang KT; Liu SH; Yang PS; Qu X; Wei FC
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4542-4550. PubMed ID: 30058692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The integration of differentially expressed genes based on multiple microarray datasets for prediction of the prognosis in oral squamous cell carcinoma.
    Zhao Y; Huang J; Chen J
    Bioengineered; 2021 Dec; 12(1):3309-3321. PubMed ID: 34224327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hsa_circ_0003829 serves as a potential diagnostic predictor for oral squamous cell carcinoma.
    Zhang H; Shen Y; Zhang B; Qian M; Zhang Y; Yang H
    J Int Med Res; 2020 Sep; 48(9):300060520936880. PubMed ID: 32993417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
    Jiang T; Xie P; Liu H
    J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of PLCE1 in Kazakh esophageal squamous cell carcinoma: implications in cancer metastasis and aggressiveness.
    Chen YZ; Cui XB; Hu JM; Zhang WJ; Li SG; Yang L; Shen XH; Liu CX; Pan QF; Yu SY; Yuan XL; Yang L; Gu WY; Chen JZ; Wang LD; Li F
    APMIS; 2013 Oct; 121(10):908-18. PubMed ID: 23659763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic and prognostic value of serum miR-99a expression in oral squamous cell carcinoma.
    Chen L; Hu J; Pan L; Yin X; Wang Q; Chen H
    Cancer Biomark; 2018; 23(3):333-339. PubMed ID: 30223386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
    Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
    PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA MINCR activates Wnt/β-catenin signals to promote cell proliferation and migration in oral squamous cell carcinoma.
    Lyu Q; Jin L; Yang X; Zhang F
    Pathol Res Pract; 2019 May; 215(5):924-930. PubMed ID: 30777615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC).
    Dong Y; Xue L; Zhang Y; Liu C; Zhang Y; Jiang N; Ma X; Chen F; Li L; Yu L; Liu X; Shao S; Guan S; Zhang J; Xiao Q; Li H; Dong A; Huang L; Shi C; Wang Y; Fu M; Lv N; Zhan Q
    J Exp Clin Cancer Res; 2022 Apr; 41(1):150. PubMed ID: 35449073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.